Innoviva Specialty Therapeutics’ Antimicrobial Therapies, XACDURO®, ZEVTERA® and NUZOLVENCE® Designated Finalists for the 2026 Prix Galien USA Best Pharmaceutical Product Award
Go back to Innoviva Specialty Therapeutics’ Antimicrobial Therapies, XACDURO®, ZEVTERA® and NUZOLVENCE® Designated Finalists for the 2026 Prix Galien USA Best Pharmaceutical Product Award| Inova Technology, Inc. (NASDAQ: INVA) | Delayed: 21.14 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $21.14 | 52 Week High | $14.15 | |||
| Open | $21.14 | 52 Week Low | $7.56 | |||
| Day High | $21.14 | P/E | N/A | |||
| Day Low | $21.14 | EPS | $0.00 | |||
| Volume | 1 | |||||
